Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis (Q34660809)

3 August 2017

1 reference

title

Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis (English)

1 reference

3 August 2017

1 reference

irritable bowel syndrome

1 reference

James L Smith

1

1 reference

PubMed ID

17685356

3 August 2017

Darrell Bayles

series ordinal

2

1 reference

3 August 2017

1 July 2007

1 reference

Journal of Food Protection

3 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 August 2017

70

1 reference

3 August 2017

7

1 reference

3 August 2017

1762-1769

1 reference

Irritable bowel syndrome: recent and novel therapeutic approaches

3 August 2017

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

New pathophysiological mechanisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Gene expression alterations of human peripheral blood monocytes induced by medium-term treatment with the TH2-cytokines interleukin-4 and -13.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

The putative role of inflammation in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Role of serotonin in the pathophysiology of the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

The spectrum of irritable bowel syndrome: A clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

The role of psychological and biological factors in postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Systematic review: the influence of geography and ethnicity in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Costs of irritable bowel syndrome in the UK and US.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Post Salmonella irritable bowel syndrome--5 year review.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Irritable bowel syndrome--post salmonella infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

5-HT in the enteric nervous system: gut function and neuropharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Differing effects of histamine and serotonin on microvascular permeability in anaesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Irritable bowel syndrome. Diagnosis is based on clinical criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Role of serotonin in the immune system and in neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Epidemiological aspects of irritable bowel syndrome in Europe and North America.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Regulation of 5-HT release from enterochromaffin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Post-infectious irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Serotoninergic neuroenteric modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Irritable bowel syndrome: a little understood organic bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4315%2F0362-028X-70.7.1762

10.4315/0362-028X-70.7.1762

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

17685356